Article ID: 695565 Health Sciences at the University of PittsburghMucus and other airway secretions that are expelled when a person with the flu coughs or exhales appear to protect the virus when it becomes airborne, regardless of humidity levels, a creative experiment conducted by the University of Pittsburgh and Virginia Tech discovered. |
Article ID: 693878 Scripps Research InstituteWith the new funding from the Gates Foundation, the Scripps Research team will expand their studies of neutralizing antibodies. |
|
|
Article ID: 693253 Vanderbilt UniversityHow a bacteria hijacked insect fertility remained a mystery for five decades, until Associate Professor of Biological Sciences Seth Bordenstein and his team helped solve it. |
Article ID: 693044 University of GeorgiaUniversity of Georgia food scientist Xiangyu Deng has created a system that can identify foodborne pathogens in a fraction of the time taken by traditional methods. |
|
Article ID: 692620 Wake Forest UniversityWake Forest University students participating in next week’s “Dining Dilemmas” have a healthy appetite for exploring bioethics and building community. |
Article ID: 692426 University of Chicago Medical CenterResearchers at the University of Chicago have developed a genetic screening tool that identified two key factors that allow the influenza virus to infect human lung cells. The technique uses new gene editing tools to create a library of modified cells, each missing a different gene, allowing scientists to see which changes impact their response to flu. This in turn could identify potential targets for antiviral drugs. |
Article ID: 691995 University of Chicago Medical CenterIn the April 5, 2018 issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase. For decades, flu vaccines have concentrated on hemagglutinin. The authors maintain that a focus on neuraminidase could lower infection rates and lessen severity. Channels: All Journal News, Cell Biology, Infectious Diseases, Vaccines, Influenza, Cell (journal), Local - Illinois Influenza, Influenca vaccine, Neuraminidase, Hemagglutinin, Viral-surface glycoproteins , Viral cellular egress, Shifting focus to neuraminidase, Vaccine effectiveness, Neutralize neuraminidase, Antibodies |
Article ID: 692097 Scripps Research InstituteScientists at The Scripps Research Institute have discovered a new aspect of the flu virus and how it interacts with antibodies in the lungs. |
Article ID: 667765 A New Drug for Pediatric Cancer, Four-Legged Help, Neurocognitive Side Effects in Young Leukemia Survivors, and More in the Children's Health News SourceNewswiseClick here for the latest research and features on Children's Health. Channels: Children's Health, Local - Virginia, AIDS and HIV, Allergies, Arthritis, Asthma, Autism, Autoimmune Diseases, Back to School, Behavioral Science, Bone Health, Bullying, Cancer, Cardiovascular Health, Complementary Medicine, Dermatology, Diabetes, Digestive Disorders, Drugs and Drug Abuse, Emergency Medicine, Environmental Health, Epilepsy, Exercise and Fitness, |